Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
about
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@en
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@nl
type
label
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@en
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@nl
prefLabel
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@en
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@nl
P2093
P2860
P921
P1433
P1476
Antithrombotic effects of rosi ...... llitus and metabolic syndrome.
@en
P2093
Antonio V Gaddi
Emmanouil Peros
Ilaria Ferrari
Leonardina Ciccarelli
Mario N Piccinni
Morena Ghelfi
Sibilla Salvadeo
P2860
P304
P356
10.1592/PHCO.25.5.637.63587
P407
P577
2005-05-01T00:00:00Z